NEOMED is committed to the Ohio IP Promise
Fostering technology commercialization & entrepreneurship
Research discoveries at NEOMED are actively commercialized with the support of The REDIzone to connect life science entrepreneurs with our research faculty. Additionally, The REDIzone is driving our industry collaborations to leverage NEOMED’s vast research infrastructure and expertise to solve commercially challenging problems.
At NEOMED, we are committed to The Ohio IP Promise. This initiative fosters a climate where innovation thrives through partnerships among universities, researchers, entrepreneurs, investors and industry. With improved collaboration, high-impact discoveries made at Ohio universities will go to market more quickly, boosting Ohio’s economy and improving its residents’ lives with new products and services.
Discover how NEOMED is Driving Economic Growth
Innovation & Research at NEOMED
-
University Hospitals (UH) and Northeast Ohio Medical University (NEOMED) have announced a new affiliation agreement that supports the joint aim of developing leadership and deploying a transformational workforce who heal, […]
-
Can exercise slow the progression of neurodegeneration in Parkinson’s disease? Sheila Fleming, Ph.D., associate professor of pharmaceutical sciences, wants to find out. Dr. Fleming, who is also director of the […]
- As College of Graduate Studies student Gabrielle Frame works toward a Ph.D., she continues to find ways to lead. The latest? Frame has been named as the inaugural recipient of [...]Read more
Contact
Maria R. Schimer
Chief Technology Transfer Officer
Phone: 330.325.6356
Email: maria@neomed.edu
Elliot Reed
Executive Director, NIICED
Phone: 330.325.6218
Email: ereed@neomed.edu